Cover Image
市場調查報告書

全球糖尿病市場

Global Diabetes Market: Industry Analysis & Outlook 2016-2020

出版商 Koncept Analytics 商品編碼 223069
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
Back to Top
全球糖尿病市場 Global Diabetes Market: Industry Analysis & Outlook 2016-2020
出版日期: 2016年12月28日 內容資訊: 英文 107 Pages
簡介

糖尿病是胰臟無法產生胰島素,或無法充分活用胰島素而產生的慢性疾病。糖尿病有第一型糖尿病,第二型糖尿病,妊娠性糖尿病3種。

本報告提供全球糖尿病市場相關調查分析、市場趨勢與發展、成長推動因素與課題、競爭情形、主要企業簡介等系統性資訊。

第1章 關於糖尿病

第2章 全球糖尿病市場

  • 糖尿病人口
  • 盛行率
  • 治療市場規模
  • 胰島素市場規模
  • 胰島素市場區隔
  • 明細:各地區

第3章 各地區分析

  • 西太平洋
  • 東南亞
  • 歐洲
  • 北美、加勒比海
  • 中東、北非
  • 中南美
  • 非洲

第4章 市場動態

  • 主要趨勢與發展
  • 成長推動因素
  • 課題

第5章 競爭情形

  • 全球市場
  • 各地區
    • 美國
    • 歐洲
    • 中國
    • 日本

第6章 企業簡介

  • 產業概要、財務概要、產業策略
    • Novo Nordisk
    • Sanofi
    • Eli Lilly
    • 武田藥品工業

第7章 市場預測

  • 市場預測
  • 預測手法

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Diabetes, often referred to as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. Diabetes is a disorder of metabolism, the process by which the body uses digested food for energy. There are two main forms of the diabetes. People with type 1 diabetes typically make none of their own insulin and therefore require insulin injections to survive. People with type 2 diabetes, the form that comprises some 90% of cases, usually produce their own insulin, but not enough or they are unable to use it properly. People with type 2 diabetes are typically overweight and sedentary, two conditions that raise a person's insulin needs. It may also be seen during pregnancy.

The report "Global Diabetes Market" provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Novo-Nordisk, Sanofi-Aventis, Eli Lilly and Takeda are being profiled.

The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing healthcare expenditure, accelerating economic growth, growing obese population, opportunities for growth in emerging markets and bariatric surgery for treating diabetes on the rise. Some of the noteworthy trends and developments of this industry are advances in medical devices, rising prevalence of diabetes and desk bound lifestyle and second hand smoke. However, the expansion of the market is hindered by increasing diabetes cost.

Table of Contents

1. Diabetes Market Overview

  • 1.1 An Introduction
  • 1.2 Types of Diabetes
  • 1.3 Diabetes Risk Factors
  • 1.4 How is Diabetes Diagnosed and Managed?
  • 1.5 Treatment of Diabetes

2. Global Diabetes Market Analysis

  • 2.1 Global Diabetic Population
  • 2.2 Global Diabetic Forecast Population
  • 2.3 Global Diabetes Population by Region
  • 2.4 Global Diabetes Population by Areas
  • 2.5 Global Diabetes Population by Gender
  • 2.6 Global Diabetes Population by Age Distribution
  • 2.7 Global Diabetes Statistics
  • 2.8 Global Undiagnosed Diabetic Population by Region
  • 2.9 Top Ten Countries for Number of Children with Type 1 Diabetes 0-14 Years
  • 2.10 Top Ten Countries/Territories for Number of People with Diabetes 20-79 Years

3. Diabetes Treatment Market

  • 3.1 Global Diabetes Care Market by Treatment Class
  • 3.2 Global Insulin Market by Segments
  • 3.3 Global Insulin Market by Region
  • 3.4 Global Insulin Users by Region
  • 3.5 Global Injectable Diabetes Drugs Sales by Value
  • 3.6 Global Injectable Diabetes Drugs Sales Forecast by Value

4. Regional Market Analysis

  • 4.1 Western Pacific
    • 4.1.1 Western Pacific - Diabetes Statistics
    • 4.1.2 China - Diabetes Statistics
    • 4.1.3 Japan - Diabetes Statistics
    • 4.1.4 Other Countries - Diabetes Statistics
  • 4.2 South-East Asia
    • 4.2.1 South-East Asia- Diabetes Statistics
    • 4.2.2 India - Diabetes Statistics
    • 4.2.3 Other Countries - Diabetes Statistics
  • 4.3 Europe
    • 4.3.1 Europe - Diabetes Statistics
    • 4.3.2 Germany- Diabetes Statistics
    • 4.3.3 Other Countries - Diabetes Statistics
  • 4.4 North America and Caribbean
    • 4.4.1 North America and Caribbean- Diabetes Statistics
    • 4.4.2 The US - Diabetes Statistics
    • 4.4.3 Other Countries - Diabetes Statistics
  • 4.5 Middle East and North Africa
    • 4.5.1 Middle East and North Africa- Diabetes Statistics
    • 4.5.2 Other Countries - Diabetes Statistics
  • 4.6 South and Central America
    • 4.6.1 South and Central America- Diabetes Statistics
    • 4.6.2 Other Countries - Diabetes Statistics
  • 4.7 Africa
    • 4.7.1 Africa - Diabetes Statistics
    • 4.7.2 Other Countries - Diabetes Statistics

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Growing Ageing Population
    • 5.1.2 Growing Urbanization
    • 5.1.3 Increasing Healthcare Expenditure
    • 5.1.4 Accelerating Economic Growth
    • 5.1.5 Growing Obese Population
    • 5.1.6 Opportunities for Growth in Emerging Markets
    • 5.1.7 Bariatric Surgery for Treating Diabetes on the Rise
  • 5.2 Market Trends
    • 5.2.1 Advances in Medical Devices
    • 5.2.2 Rising Prevalence of Diabetes
    • 5.2.3 Desk Bound Lifestyle and Second hand Smoke
  • 5.3 Challenges
    • 5.3.1 Increasing Diabetes Cost

6. Competitive Landscape

  • 6.1 Top Ten Diabetes Drug by Company
  • 6.2 Global Diabetes Care Market Share by Company
  • 6.3 Global Modern Insulin Market Share by Company
  • 6.4 The US Insulin Pump Market Share by Company
  • 6.5 The US Modern Insulin Market Shares by Company
  • 6.6 Europe Modern Insulin Market Shares by Company
  • 6.7 Chinese Insulin Market Shares by Company
  • 6.8 Japanese Modern Insulin Market Shares by Company

7. Company Profiles

  • 7.1 Sanofi
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Takeda
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Eli Lilly
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Novo Nordisk
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Charts

  • Types of diabetes
  • Global Diabetic Population (2007-2015)
  • Global Diabetic Forecast Population (2016-2020)
  • Global Diabetes Population by Region (2015
  • Global Diabetes Population by Areas (2015)
  • Global Diabetes Population by Gender (2015)
  • Global Diabetes Statistics (2015)
  • Top Ten Countries for Number of Children with Type 1 Diabetes 0-14 Years (2015)
  • Top Ten Countries/Territories for Number of People with Diabetes 20-79 Years (2015)
  • Global Diabetes Care Market by Treatment Class (August 2016)
  • Global Insulin Market Forecast by Value (2016-2020)
  • Global OAD Market Forecast by Value (2016-2020)
  • Global GLP-1 Market Forecast by Value (2016-2020)
  • Global Insulin Market by Segments (August 2016)
  • Global Insulin Market by Region (August 2016)
  • Global Injectable Diabetes Drugs Sales by Value (2011-2015)
  • Global Injectable Diabetes Drugs Sales Forecast by Value (2016-2020)
  • Chinese Diabetes Care Market by Treatment Class (August 2016)
  • Chinese Insulin Market by Segments (August 2016)
  • Japanese Insulin Market by Segments (August 2016)
  • Europe Diabetes Care Market by Treatment Class (August 2016)
  • European Insulin Market by Segments (August 2016)
  • The US Diabetes Care Market by Treatment Class (August 2016)
  • The US Insulin Market by Segments (August 2016)
  • Global Ageing Population (2006-2015)
  • Global Urban Population (2007-2015)
  • Global Healthcare Expenditure (2007-2015)
  • Global GDP Growth (2007-2015)
  • Global Obese Population (2006-2015)
  • Global Diabetes Care Market Share by Company (August 2016)
  • Global Modern Insulin Market Share by Company (August 2016)
  • The US Modern Insulin Market Shares by Company (August 2016)
  • Europe Modern Insulin Market Shares by Company (August 2016)
  • Chinese Insulin Market Shares by Company (August 2016)
  • Japanese Modern Insulin Market Shares by Company (August 2016)
  • Sanofi's Net Sales Share by Business Segment (2015)
  • Sanofi's Net Sales Share by Region (2015)
  • Sanofi's Net Sales and Net Income (2011-2015)
  • Takeda's Revenue Share by Business Segments (2016)
  • Takeda's Revenue Share by Region (2016)
  • Takeda's Revenues and Net Income (2012-2016)
  • Eli Lilly's Revenue Share by Business Segments (2015)
  • Eli Lilly's Revenue Share by Region (2015)
  • Eli Lilly's Revenues and Net Income (2011-2015)
  • Novo Nordisk's Net Sales Share by Business Segments (2015)
  • Novo Nordisk's Net Sales Share by Region (2015)
  • Novo Nordisk's Net Sales and Net Profit (2011-2015)

List of Tables

  • Global Diabetes Population by Age Distribution (2015)
  • Proportion and Number of People (20-79 Years) Living With Diabetes Who Are Undiagnosed By Region (2015)
  • Global Insulin Users by Region (2015)
  • Western Pacific - Diabetes Statistics (2015)
  • China - Diabetes Statistics (2015)
  • Japan - Diabetes Statistics (2015)
  • Diabetes in Other Countries of South East Asia (2015)
  • South-East Asia- Diabetes Statistics (2015)
  • India - Diabetes Statistics (2015)
  • Diabetes in Other Countries of South East Asia (2015)
  • Europe - Diabetes Statistics (2015)
  • Germany- - Diabetes Statistics (2015)
  • Diabetes in Other Countries of Europe (2015)
  • North America and Caribbean- Diabetes Statistics (2015)
  • The US - Diabetes Statistics (2015)
  • Diabetes in Other Countries of the North American and Caribbean Region (2015)
  • Middle East and North Africa- Diabetes Statistics (2015)
  • Diabetes in Other Countries of the Middle East and North Africa Region (2015)
  • South and Central America- Diabetes Statistics (2015)
  • Diabetes in Other Countries of the South and Central America Region (2015)
  • Africa - Diabetes Statistics (2015)
  • Other Countries - Diabetes Statistics (2015)
  • Top Ten Diabetes Drug by Company (2015)
Back to Top